Skip to content
Trial Eligibility
Menu

A Neurosensory Account of Anxiety and Stress (Study 2)

NCT07079839

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study will take a basic neuroscience approach to investigate pathological mechanisms underlying PTSD. Additionally, the study aims to identify how Transcranial Alternating Current Stimulation (tACS) brain stimulation can modulate and correct neural networks and related emotions of anxious arousal and hypervigilance, with the goal of assessing tACS brain stimulation technology as a novel intervention for symptoms of anxiety.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Threat-related Sensory Cortical (SC) Disinhibition
  • Posttraumatic Stress Disorder (PTSD)

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 50 years
Sex
All
Healthy volunteers
Accepted
Sponsor
The University of Texas Health Science Center, Houston
Last updated on ClinicalTrials.gov
September 11, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 1

  • The University of Texas Health Science Center at Houston · Houston, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.